WELCOME TO THE WORCESTERSHIRE JOINT MEDICINES FORMULARY
This Formulary is intended for use by staff working within the Worcestershire area, in either Primary, Secondary or Mental Health care Trusts and is available via the Internet.
Information contained herein should not be used or issued to persons outside of NHS Worcestershire without the prior approval of the Area Prescribing Committee (APC) who manage the database.
The aim of the Area Prescribing Committee is to manage medicines usage across the Worcestershire Health Economy. The central principles of rational prescribing and medicines use, namely clinical and cost effectiveness, appropriateness (including convenience), safety and financial management, will guide the thinking and outputs of the Committee. The membership comprises of representatives from Worcestershire CCGs, Worcestershire Acute Hospitals Trust, Worcestershire Health & Care Trust, and a lay member.
Only formulary approved medicines are displayed and those medicines which are restricted (by specialist or indication) are shown as are first and second line choices for some medicines.
The database is formatted in accordance with BNF chapter classification for ease of use and also includes hyperlinks to the e-BNF, e-BNFc and to the electronic medicines compendium which holds Summaries of Product Characteristics. Searches can be undertaken by medicine name, class or condition.
NICE information is available at www.nice.org.uk but some chapters do also provide links to appropriate NICE guidelines.
Comments about any aspect of the database can be made by utilising the feedback section. The APC would be pleased to receive any comments or criticisms.
New Drug Applications
An application is required for any new product likely to be used in more than one patient, which is not on the Worcestershire formulary. This applies to products normally prescribed on FP10 or kept by the hospital pharmacy. It also applies to new indications for use of existing products on the formulary.
Application Form **Updated April 2011**
Application Form Guidance **Updated July 2010**
Application Form Priority Scoring Tool **NEW**
West Midlands SHA Cancer Drugs Funding Information **NEW - October 2010**
For more information about the decision-making process undertaken by APC, please read our Operating Procedure guidelines
WAHT High Cost Drugs and Individual Funding Requests
Procedure for approval of High Cost Drugs
An individual funding request is a request received from a provider, or a patient with explicit support from a clinician, which seeks funding for a single identified patient for a specific treatment.
Procedure for Approval of Individual Funding Requests by Clinical Director of Pharmacy
Updated June 2011
Visits = 53670